Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07274800 | Adjuvant Ultra-Hypofractionated vs Hypofractionated Radiotherapy for Early Breast Cancer(UHF vs HF-EBC) | completed | N/A | 60 | Zagazig UniversityOTHER_GOV | 1 | Dec 10, 2025 | clinicaltrials |
| NCT00984399 | Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen | completed | N/A | 31 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 9, 2025 |
| clinicaltrials |
| NCT04175639 | mHealth Behavioral Cancer Pain Intervention for Medically Underserved Patients(ICAN-NC) | completed | N/A | 180 | Duke UniversityOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT04735367 | Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole | completed | — | 42 | PfizerINDUSTRY | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07272447 | Effect of Hand Message on Catheter Insertion | completed | N/A | 60 | University of YalovaOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT03542175 | A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy | completed | Phase 1 | 31 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT06219434 | Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer | completed | N/A | 15 | Thomas Jefferson UniversityOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07269860 | Impact of Osteopathic Manipulative Medicine on Sentinal Lymph Node Biopsy Dye and Tracer Uptake(OMM on SLNB) | completed | N/A | 27 | University of ArizonaOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT02473042 | Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) | completed | N/A | 188 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT04999917 | Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer(BrIMA) | completed | N/A | 206 | XEOS MedicalINDUSTRY | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06125145 | Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study(GAP) | completed | N/A | 30 | University of California, DavisOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT02783690 | A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation | completed | Phase 2 | 88 | Mayo ClinicOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT03807765 | Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases | completed | Phase 1 | 14 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04206891 | CDH1 Germline Mutations in Lobular Breast Cancer | completed | — | 421 | European Institute of OncologyOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05253911 | Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.(TRACE) | completed | — | 49 | iOMEDICO AGINDUSTRY | 2 | Dec 4, 2025 | clinicaltrials |
| NCT05520723 | Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED(PRIMED) | completed | Phase 2 | 50 | MedSIROTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT02950259 | Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) | completed | Phase 1 | 16 | Providence Health & ServicesOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT05190770 | A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer | completed | Phase 2 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT03284684 | Kinetics of Perioperative Circulating DNA in Cancer Surgery(Periop ctDNA) | completed | — | 30 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer(APHINITY) | completed | Phase 3 | 4,804 | Hoffmann-La RocheINDUSTRY | 42 | Nov 28, 2025 | clinicaltrials |
| NCT05383170 | A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers(Catalyst) | completed | Phase 1 / Phase 2 | 6 | Cytovation ASINDUSTRY | 5 | Nov 28, 2025 | clinicaltrials |
| NCT05757427 | Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer Detection | completed | N/A | 73 | MVG Industries SASINDUSTRY | 1 | Nov 26, 2025 | clinicaltrials |
| NCT01147965 | QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA | completed | Phase 1 / Phase 2 | 43 | NantCell, Inc.INDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT02639026 | Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers | completed | Phase 1 | 53 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT06101849 | Chronic Cancer Pain Management Program(ICMP) | completed | N/A | 23 | Hamilton Health Sciences CorporationOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT01373710 | Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis(HIT) | completed | Phase 1 / Phase 2 | 34 | Institut CurieOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT01975142 | Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment. | completed | Phase 2 | 155 | Institut CurieOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06911892 | Comparative Sensory Mapping of Regional Anesthesia Techniques in Breast Cancer Surgery | completed | — | 36 | Samsun UniversityOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06233383 | Developing Screening Clinical Breast Examination Implementation Strategies in South Africa | completed | — | 80 | Yale UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT06500858 | MBC Physical Activity Study | completed | N/A | 12 | Thomas Jefferson UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07240584 | Exercise Prehabilitation of Breast Cancer(Prehab of BC) | completed | N/A | 30 | University of Health Sciences Balikesir Hospital Eduation and ResearchOTHER_GOV | 1 | Nov 21, 2025 | clinicaltrials |
| NCT05472532 | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)(INOVOLINE) | completed | N/A | 101 | Hospices Civils de LyonOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT03079011 | PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection(PADA-1) | completed | Phase 3 | 1,017 | UNICANCEROTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06120439 | Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy | completed | N/A | 96 | Jun ZhangOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06408038 | Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer(DP METABREAST) | completed | N/A | 60 | Institut Claudius RegaudOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05573022 | Impact of a Patient Decision Aid Intervention(IMPACTT) | completed | N/A | 274 | Vejle HospitalOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT05950685 | Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and Treatments | completed | — | 1,602 | Ifat KleinOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT03371017 | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer(IMpassion132) | completed | Phase 3 | 595 | Hoffmann-La RocheINDUSTRY | 28 | Nov 12, 2025 | clinicaltrials |
| NCT04647487 | A Study of LY3484356 in Women With Breast Cancer Before Having Surgery(EMBER-2) | completed | Phase 1 | 87 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 12, 2025 | clinicaltrials |
| NCT06133348 | Promoting Resilience in Women With Breast Cancer(PRISM) | completed | N/A | 43 | University of Alabama at BirminghamOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT02593175 | Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC | completed | Phase 2 | 43 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT03396445 | Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001) | completed | Phase 1 | 182 | Merck Sharp & Dohme LLCINDUSTRY | 7 | Nov 5, 2025 | clinicaltrials |
| NCT05978232 | NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients | completed | N/A | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06106282 | Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) | completed | — | 105 | Mayo ClinicOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT07223476 | Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal(PORTRAIT) | completed | — | 1,926 | Novartis PharmaceuticalsINDUSTRY | 1 | Oct 31, 2025 | clinicaltrials |
| NCT03620643 | Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours(ROLo) | completed | Phase 2 | 33 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 30, 2025 | clinicaltrials |
| NCT03036488 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) | completed | Phase 3 | 1,174 | Merck Sharp & Dohme LLCINDUSTRY | 21 | Oct 29, 2025 | clinicaltrials |
| NCT07221071 | Supporting Women With Breast Cancer to Prepare for Treatment (The Prepare Study)(Prepare) | completed | N/A | 42 | Endeavor HealthOTHER | 1 | Oct 27, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Dec 10, 2025source: clinicaltrials